Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Teva Pharma announces the launch of generic Pristiq (desvenlafaxine) extended-release tablets, 25, 50 and 100 mg, in the U.S. (35.08 +0.06)Pristiq had annual sales of approximately $883 million in the U.S. according to IMS data as of December 2016. Pristiq is a registered trademark of Pfizer (<strong>PFE</strong>)</td> </tr></table>"